Jones-Brando's quick experiment spurred two years of "furious" research to see what impact sulforaphane had on SARS-CoV-2, as well as the common cold, in both human cells grown in the lab and in mice
While significantly cheaper, the results dont compare to newer medications
We propose that the developed methods will simplify and accelerate basic and drug discovery research for heart diseases and could also be implemented to characterize fibrosis in other diseases
Specific triggers for medical consultation include achieving less than 5% body weight reduction after reaching the maintenance dose (for Wegovy, after 12 weeks at 2.4 mg as per FDA labeling), prolonged weight loss plateau despite adherence, or intolerable side effects preventing dose escalation to therapeutic levels
Instead, it reveals predispositions in peptide-pathway genes that, combined with your biomarkers and clinical presentation, should be interpreted with a qualified healthcare provider to inform more personalized dosing decisions
Neuroinflammation 14 , 99 (2017)